NEW YORK--(BUSINESS WIRE)--Deerfield has committed up to $300 million to create and build Aralez Pharmaceuticals Ltd. Aralez will bring together a proven management team with the existing products and pipelines from POZEN Inc. and Tribute Pharmaceuticals Canada, to form a new specialty pharmaceutical company with exceptional prospects. Deerfield will provide $75 million in 6 year convertible notes, up to $25 million in equity and a $200 million commitment available for future product acquisitio
| < Prev | Next > |
|---|
